is a biopharmaceutical company based in alpharetta georgia that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals their main focus is on diseases affecting the back of the eye or retina alimera was founded in june 2003 by dan myers daniel white dave holland and mark testerman three of the founders were previously part of ciba vision ophthalmics which was renamed novartis ophthalmics following a merger in 2004 alimera sciences introduced soothe emollient lubricant eye drops for people with dry eyes soothe was the first lubricant eye drop to feature restoryl a lipid restorative that works to re establish the lipid oily layer of tears promoting sustained moisture retention soothe was a mineral oil in water emulsion developed by chris brancewicz then at clarkson university for ocular research of boston during 1996 2001 soothe was sold to bausch lomb in august 2007 in 2006 alimera sciences developed and submitted for u s food and drug administration fda approval an application for a prescription to over the counter drug switch of 0 025 ketotifen fumarate for the temporary relief of ocular itch this product alaway was approved by the fda in december 2006 and was sold along with a